Peter DeNardo | CapComm Partners |
James McCullough | Chief Executive Officer |
James Sterling | Chief Financial Officer |
Thomas McLain | President |
Fergus Fleming | Chief Technology Officer |
Dan Arias | Stifel |
Mark Massaro | BTIG |
Yi Chen | HCW |
Good morning and welcome to the Renalytix Conference Call to review First Quarter Fiscal 2023 Financial Results. At this time, all participants are in a listen-only mode.
We will be facilitating a question-and-answer session towards the end of today’s call.
As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Peter DeNardo of CapComm Partners for a few introductory comments.